Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

US Bioservices now dispenses AUSTEDO

February 16, 2018

The U.S. Food and Drug Administration has approved AUSTEDO (deutetrabenazine) for the treatment of tardive dyskinesia in adults and chorea associated with Huntington’s disease (HD).